Brian Corvese - Feb 4, 2022 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
By: /s/ Christine Klaskin as Attorney-in-Fact for Brian Corvese
Stock symbol
AGEN
Transactions as of
Feb 4, 2022
Transactions value $
$0
Form type
4
Date filed
2/8/2022, 05:12 PM
Previous filing
Oct 20, 2021
Next filing
Mar 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option (Right to Buy) Award $0 +150K $0.00 150K Feb 4, 2022 Common Stock 150K $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023.